Release of Phase III trial data of a small cap company's drug for opioid addiction expected in January - February 2012 Read ReportSee Other Upcoming Events
Review the Top 10 Small Cap Biotech performers over the last month and their Drivers. This report lists the companies, their stock performance over the last month and some drivers that have contributed to the rise in the stock price. (April 7, 2010 through May 7, 2010)
VRTX's HCV drug Telaprevir received FDA approval on May 23, 2011. New BioMedicine had issued a report on this event on May 3, 2011. To read more about the drug, the disease, the market, the competition, etc. access it at the link below.
All Upcoming Events In Biotechnology - January 20, 2012
